Gliptins: IQWiG assessed data subsequently submitted by the manufacturer

Studies on sitagliptin also relevant for fixed combination of sitagliptin/metformin: Hint of added benefit / vildagliptin still without advantages

2013-10-09

(Press-News.org) The German Institute for Quality and Efficiency in Health Care (IQWiG) analysed additional data on drugs from the group of gliptins. The drug manufacturers had subsequently submitted these data to the Federal Joint Committee (G-BA) in the commenting procedure. The Institute came to a different conclusion on the fixed combination of sitagliptin/metformin: As for the single agent sitagliptin before, there are now hints of an added benefit for this fixed combination. However, IQWiG still does not see any advantages of vildagliptin and the fixed combination of vildagliptin and metformin versus current standard treatment.

First assessment: hints of added benefit only for sitagliptin

Gliptins are drugs used for the treatment of people with type 2 diabetes mellitus who cannot sufficiently lower their high levels of blood glucose with dietary changes and exercise alone or do not tolerate other oral antidiabetics. In its dossier assessment of gliptins according to the Act on the Reform of the Market for Medicinal Products (AMNOG) on 1 July 2013, IQWiG concluded that there were hints of an added benefit solely for sitagliptin as a single agent. This applied to the therapeutic indication "sitagliptin plus metformin" in comparison with a sulfonylurea plus metformin.

Metformin dose not in compliance with its approval in all patients

The manufacturer used two studies (P803 and P024) for the comparison of sitagliptin plus metformin with sulfonylurea plus metformin, both in the dossier on the free combination of sitagliptin (single agent) and metformin and in the dossier on the fixed combination.

Whereas a hint of an added benefit could be derived for sitagliptin in the free combination, the data were unsuitable for the fixed combination. The reason was that the approval stipulates a dose of at least 1700 mg metformin for the fixed combination. But patients who received a lower dose of metformin were also included in both studies. The number of these patients remained unclear.

Manufacturer subsequently submitted separate analyses according to dosage

In the commenting procedure, the manufacturer now presented subgroup analyses, which differentiated between patients with approval-compliant (at least 1700 mg) and lower dosage. These analyses showed that the study results did not depend on the metformin dosage, which means that the results of the two studies could also be used for assessing the fixed combination.

Hints of added benefit now also for the fixed combination

According to the results, there is a hint of a major added benefit – only in men, however – with regards to overall survival in comparison with the sulfonylurea glipizide plus metformin. There was a non-quantifiable added benefit due to fewer hypoglycaemias in women and men, but these results were only of limited robustness.

Compared with the sulfonylurea glimepiride, IQWiG sees a hint of a minor added benefit independent from the sex regarding hypoglycaemias – provided the treatment goal is near-normal levels of blood glucose.

Vildagliptin: Additional data did not change the result of the assessment

The manufacturer of vildagliptin as single agent and as fixed combination with metformin also submitted additional data in the commenting procedure. But they do not change the result of the dossier assessment dated July 2013: IQWiG does not see advantages neither of the single agent nor of the fixed combination in comparison with standard treatment.

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturers' dossiers and the IQWiG dossier assessments, the G-BA conducted commenting procedures, in which the manufacturers submitted additional information. The G-BA subsequently commissioned IQWiG to assess the data subsequently submitted.

If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The Institute sent the addenda on sitagliptin/metformin and on vildagliptin and vildagliptin/metformin to the contracting agency on 29 August 2013. The G-BA then decides on the extent of the added benefit in each case, thus completing the early benefit assessment.

###

ELSE PRESS RELEASES FROM THIS DATE:

Crystal mysteries spiral deeper, NYU chemists find

2013-10-09

New York University chemists have discovered crystal growth complexities, which at first glance appeared to confound 50 years of theory and deepened the mystery of how organic crystals form. But, appearances can be deceiving. Their findings, which appear in the latest edition of Proceedings of the National Academy of Sciences, have a range of implications -- from the production of pharmaceuticals and new electronic materials to unraveling the pathways for kidney stone formation. The researchers focused on L-cystine crystals, the chief component of a particularly nefarious ...

'Chimpanzees of a feather sit together': Friendships are based on homophily in personality

2013-10-09

This news release is available in German. Jorg Massen (University of Vienna) and Sonja Koski (University of Zurich) together measured chimpanzee personality in two zoos with behavioural experiments and years of observations of chimpanzee behaviour. They also carefully logged which chimpanzee sat in body contact with whom most. "This is a clear sign of friendship among chimpanzees", explains Jorg Massen. Subsequently, the researchers tested, if those chimpanzees who sit together frequently have similar or different personality types. "We found that, especially ...

Household chaos may be hazardous to a child's health

2013-10-09

COLUMBUS, Ohio – Kindergarten-age children have poorer health if their home life is marked by disorder, noise and a lack of routine and they have a mother who has a chaotic work life, new research suggests. The results show the importance of order and routine in helping preschoolers stay healthy and develop to the best of their potential, said Claire Kamp Dush, lead author of the study and assistant professor of human sciences at The Ohio State University. "Children need to have order in their lives," Kamp Dush said. "When their life is chaotic and not predictable, ...

IQWiG: Reliable assessment of drugs is only possible on the basis of clinical study reports (CSRs)

2013-10-09

In 2012 researchers from the German Institute for Quality and Efficiency in Health Care (IQWiG) presented a study in the BMJ analysing information sources used in 16 health technology assessment (HTA) reports of drugs ("benefit assessments"). This study clearly demonstrated that publicly available sources, such as scientific journals and entries posted in trial registries ("registry reports"), contained far less information on methods and outcomes of clinical trials than non-public CSRs prepared by pharmaceutical companies. In a second article published today in PLOS ...

New mechanism preserving genomic integrity and is abnormal in the rare DiGeorge syndrome

2013-10-09

An international team of scientists—including researchers at GENYO, the Centre for Genomics and Oncological Research (Pfizer-University of Granada- Andalusian Regional Government)—has described a molecular mechanism that facilitates the defence of the human genome against "bombarding" by mobile DNA sequences. Abnormalities in the mechanism could be responsible for some symptoms of DiGeorge syndrome, a rare disease. The research could in the future help develop new therapies against the disease, which is caused by the microdeletion of a small part of chromosome 22. The ...

No serious adverse reactions to HPV vaccination

2013-10-09

Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if there are any serious adverse effects of the vaccine. Their results show no significant increase of the examined diseases in the vaccinated girls relative to their unvaccinated peers. The study included almost a million Swedish and Danish girls born between 1988 and 2000, and compared roughly 300,000 girls who had been HPV vaccinated with 700,000 who ...

Penn study: Visits to multiple HIV clinics linked to poorer outcomes

2013-10-09

PHILADELPHIA—Patients who received care at multiple HIV clinics—as opposed to only one— were less likely to take their medication and had higher HIV viral loads, a new study published in the journal AIDS and Behavior of almost 13,000 HIV patients in Philadelphia from Penn Medicine found. The findings reinforce the notion that continuous care with one provider/clinic is optimal for outcomes and even reducing transmissions, and can help cut down on duplicative HIV services that contribute to higher health care costs. "It's about retention in care, but also continuity, ...

Scientists use blur to sharpen DNA mapping

2013-10-09

HOUSTON – (Oct. 9, 2013) – With high-tech optical tools and sophisticated mathematics, Rice University researchers have found a way to pinpoint the location of specific sequences along single strands of DNA, a technique that could someday help diagnose genetic diseases. Proof-of-concept experiments in the Rice lab of chemist Christy Landes identified DNA sequences as short as 50 nucleotides at room temperature, a feat she said is impossible with standard microscopes that cannot see targets that small, or electron microscopes that require targets to be in a vacuum or cryogenically ...

Peer pressure's influence calculated by mathematician

2013-10-09

A mathematician has calculated how peer pressure influences society. Professor Ernesto Estrada, of the University of Strathclyde's Department of Mathematics and Statistics, examined the effect of direct and indirect social influences – otherwise known as peer pressure – on how decisions are reached on important issues. Using mathematical models, he analysed data taken from 15 networks – including US school superintendents and Brazilian farmers – to outline peer pressure's crucial role in society. Professor Estrada said: "Our modern society is a highly-interconnected ...

Discovery of a 2,700-year-old portico in Greece

2013-10-09

A 2,700-year-old portico was discovered this summer on the site of the ancient city of Argilos in northern Greece, following an archaeological excavation led by Jacques Perreault, Professor at the University of Montreal's Centre of Classical Studies and Zisis Bonias, an archaeologist with the Hellenic Ministry of Culture and Sports. In ancient Greece, the portico—stoa in Greek—was a long, open structure that often housed shops and delineated public squares from the city—the agora. "Porticos are well known from the Hellenistic period, from the 3rd to 1st century BC, but ...